Longitudinal Metabolomics Reveals Metabolic Dysregulation Dynamics in Patients with Severe COVID-19
2024

Metabolic Dysregulation in Severe COVID-19 Patients

Sample size: 118 publication 10 minutes Evidence: moderate

Author Information

Author(s): Uchimido Ryo, Kami Kenjiro, Yamamoto Hiroyuki, Yokoe Ryo, Tsuchiya Issei, Nukui Yoko, Goto Yuki, Hanafusa Mariko, Fujiwara Takeo, Wakabayashi Kenji

Primary Institution: Department of Intensive Care Medicine, Institute of Science Tokyo

Hypothesis

This study aimed to investigate metabolic dysregulation over time in patients with severe COVID-19 requiring mechanical ventilation.

Conclusion

The study elucidated the temporal differences in metabolic dysregulation between survivors and non-survivors of severe COVID-19.

Supporting Evidence

  • 38 differential metabolites were identified as early-stage indicators of metabolic dysregulation.
  • 84 late-stage differential metabolites showed significant changes in non-survivors.
  • 3 consistent differential metabolites were identified across all time zones.

Takeaway

Doctors studied the blood of very sick COVID-19 patients to see how their bodies changed over time, finding that some patients got worse while others got better.

Methodology

This was a single-center, prospective, observational study analyzing 236 serum samples from 118 adult patients on mechanical ventilation.

Potential Biases

Potential bias due to the exclusion of patients not requiring mechanical ventilation.

Limitations

The study's single-center design may limit the generalizability of the results, and the timing of sample acquisition was not constant.

Participant Demographics

Median age was 58 years for survivors and 71 years for non-survivors; 18% of survivors and 20% of non-survivors were female.

Statistical Information

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/metabo14120656

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication